ClinicalTrials.Veeva

Menu

Video-Based Intervention in Reducing Anxiety in Patients Undergoing Lung Cancer Screening

City of Hope logo

City of Hope

Status

Completed

Conditions

Lung Carcinoma
Anxiety
No Evidence of Disease

Treatments

Other: questionnaire administration
Other: quality-of-life assessment
Other: Best Practice
Other: educational intervention

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT02288416
NCI-2014-02220 (Registry Identifier)
14169 (Other Identifier)

Details and patient eligibility

About

This pilot trial studies a video-based intervention in reducing anxiety in patients undergoing lung cancer screening. Giving a video-based intervention to patients prior to lung cancer screening may reduce anxiety and improve the well-being and quality of life.

Full description

PRIMARY OBJECTIVES:

I. Test the feasibility and acceptability of the video-based intervention.

SECONDARY OBJECTIVES:

I. To describe incidence, degree, and duration of screen-related anxiety among individuals scheduled to undergo low-dose computed tomography (CT) scan (LDCT) for lung cancer screening (LCS).

II. To describe baseline patient characteristics and pre-screening anxiety levels.

III. To describe the preliminary outcomes on screen-related anxiety for patients both not in the intervention group and those in the intervention group.

OUTLINE: Patients are assigned to 1 of 2 groups.

GROUP I: Patients receive standard of care following LCS consisting of routine visits and telephone contact with the LCS program nurse practitioner and coordinator.

GROUP II: Patients undergo a video-based intervention prior to undergoing LCS. Patients watch a 5-minute video that focuses on preparing patients for LCS by providing information on the following: program team and contact information; reason to be screened; screening eligibility; how screening is performed; what to expect on the day of screening; what to expect after screening; what to expect if result is positive; what to expect if result is negative; and risks of screening. Patients also receive an educational handbook. Patients with positive scans (a Lung-Imaging Reporting and Data Systems [RADS] 3 or 4) receive additional brochure and nursing support within 1 week after notification of scan results.

After completion of LCS, patients are followed up at 1 week and then at 3 and 7 months.

Enrollment

20 patients

Sex

All

Ages

55+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • This study will be conducted in people scheduled to undergo baseline LDCT as part of the City of Hope (COH) LCS program
  • There are no restrictions related to performance status and life expectancy
  • All subjects must have the ability to understand and the willingness to participate in the informed consent process, although a waiver of written informed consent is obtained for this study

Exclusion criteria

  • Patients who do not speak or read, because all intervention materials, including the video and written materials are in English
  • Subjects, who in the opinion of the investigator, may not be able to comply with study procedures

Trial design

Primary purpose

Supportive Care

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

20 participants in 2 patient groups

Group I (standard of care)
Active Comparator group
Description:
Patients receive standard of care following LCS consisting of routine visits and telephone contact with the LCS program nurse practitioner and coordinator.
Treatment:
Other: Best Practice
Other: quality-of-life assessment
Other: questionnaire administration
Group II (video-based intervention)
Experimental group
Description:
Patients undergo a video-based intervention prior to undergoing LCS. Patients watch a 5-minute video that focuses on preparing patients for LCS by providing information on the following: program team and contact information; reason to be screened; screening eligibility; how screening is performed; what to expect on the day of screening; what to expect after screening; what to expect if result is positive; what to expect if result is negative; and risks of screening. Patients also receive an educational handbook. Patients with positive scans (a Lung-RADS 3 or 4) receive additional brochure and nursing support within 1 week after notification of scan results.
Treatment:
Other: educational intervention
Other: quality-of-life assessment
Other: questionnaire administration

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems